Results For The Quarter Ended 31.12.2025
Filed with BSE · · 5 pages · English
Vista Pharmaceuticals Ltd. on 6ix
Earlier from Vista Pharmaceuticals
- Vista Pharmaceuticals Ltd. Press Release Feb 05 2026
- Update on board meeting
- Board Meeting Intimation for 1. Unaudited Financial Results For The Quarter And Nine Months Ended 31.12.2025.2. Limited Review Report Quarter And Nine Months 31.12.2025.3. Any Other Business With The Permission Of The Chair.
- Vista Pharmaceuticals Ltd. Press Release Feb 03 2026
- Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - 'Joint Venture Partnership Between Pleiades Therapeutics And Vista Pharmaceuticals Ltd'
Later from Vista Pharmaceuticals
- Board Meeting Outcome for Un Audited Financial Results For The Quarter Ended 31.12.2025
- Vista Pharmaceuticals Ltd. Press Release Feb 13 2026
- Closure of Trading Window
- Vista Pharmaceuticals Ltd. Press Release Mar 27 2026
- Vista Pharmaceuticals Ltd. Press Release Apr 29 2026
Follow Vista Pharmaceuticals into a list and get an email when it puts out news.
Follow Vista Pharmaceuticals